Lucinda Crabtree
Director of Finance/CFO at MORPHOSYS AG
Net worth: - $ as of 31/03/2024
Profile
Lucinda Crabtree is currently the Chief Financial Officer at MorphoSys AG since 2023.
Prior to this, she was the Chief Financial Officer at Autolus Therapeutics Plc from 2020 to 2023.
Dr. Crabtree received her undergraduate and doctorate degrees from University College London.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
AUTOLUS THERAPEUTICS PLC
-.--% | 01/03/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Lucinda Crabtree active positions
| Companies | Position | Start |
|---|---|---|
| MORPHOSYS AG | Director of Finance/CFO | 07/08/2023 |
Former positions of Lucinda Crabtree
| Companies | Position | End |
|---|---|---|
| AUTOLUS THERAPEUTICS PLC | Director of Finance/CFO | 07/08/2023 |
Training of Lucinda Crabtree
| University College London | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| MORPHOSYS AG | Health Technology |
| AUTOLUS THERAPEUTICS PLC | Health Technology |
- Stock Market
- Insiders
- Lucinda Crabtree
